Decreased albumin to INR ratio is a prognostic marker of 30-day mortality in neonatal sepsis: a retrospective study

Authors

  • Xiangwen Tu Laboratory of Eugenics Genetics, Ganzhou Women and Children's Health Care Hospital, Ganzhou, Jiangxi, China
  • Junkun Chen Laboratory of Eugenics Genetics, Ganzhou Women and Children's Health Care Hospital, Ganzhou, Jiangxi, China
  • Wen Liu Neonatal intensive care Unit, Ganzhou Women and Children's Health Care Hospital, Ganzhou, Jiangxi, China https://orcid.org/0009-0006-5514-066X

DOI:

https://doi.org/10.3855/jidc.20968

Keywords:

Albumin, international normalized ratio, mortality, neonatal sepsis, prognosis

Abstract

Introduction: Neonatal sepsis is a leading cause of neonatal mortality. This study aims to assess the clinical significance of the serum albumin (ALB) to international normalized ratio (INR) ratio (AIR) as a predictor for 30-day mortality in neonates with sepsis.

Methodology: Neonates diagnosed with sepsis between January 2019 and December 2022 were included. Admission data were collected, enabling the categorization of neonates into survival and non-survival groups. Logistic regression analyses and receiver operating characteristic (ROC) curves, were employed.

Results: A total of 195 neonates with sepsis were analyzed. The non-survival group exhibited significantly lower AIR compared to the survival group. Multivariate analysis identified low AIR as an independent risk factor (hazard ratio [HR]: 9.091, p < 0.001), achieving an area under the curve (AUC) of 0.746 for AIR. The sensitivity and specificity of AIR were 79.31% and 66.87%, respectively.

Conclusions: AIR serves as a cost-effective and easily obtainable marker in neonatal sepsis research. It emerges as an independent predictor of adverse outcomes in neonatal sepsis, demonstrating good predictive capabilities.

Downloads

Published

2025-09-30

How to Cite

1.
Tu X, Chen J, Liu W (2025) Decreased albumin to INR ratio is a prognostic marker of 30-day mortality in neonatal sepsis: a retrospective study. J Infect Dev Ctries 19:1370–1376. doi: 10.3855/jidc.20968

Issue

Section

Original Articles